Chromium and insulin resistance
- 14 December 2003
- journal article
- Published by Cambridge University Press (CUP) in Nutrition Research Reviews
- Vol. 16 (2), 267-275
- https://doi.org/10.1079/nrr200366
Abstract
Insulin resistance leads to the inability of insulin to control the utilization and storage of glucose. It is associated initially with elevated levels of circulating insulin followed by glucose intolerance which may progress to type 2 diabetes, hyperlipidaemia, hypertension, obesity and cardiovascular diseases. While the causes of these diseases are multifactorial, one nutrient that is associated with all of these abnormalities is Cr. In the presence of Cr, in a biologically active form, much lower levels of insulin are required. Modern diets, which are often high in refined carbohydrates, are not only low in Cr, but lead to enhanced Cr losses. In response to the consumption of refined carbohydrates, there is a rapid rise in blood sugar leading to elevations in insulin that cause a mobilization of Cr. Once mobilized, Cr is not reabsorbed but lost via the urine leading to decreased Cr stores. Several studies involving both human subjects and experimental animals have reported improvements in insulin sensitivity, blood glucose, insulin, lipids, haemoglobin A1c, lean body mass and related variables in response to improved Cr nutrition. However, not all studies have reported beneficial effects associated with improved Cr nutrition. Well-controlled human studies are needed to document an unequivocal effect of Cr on insulin sensitivity in human subjects. Studies need to involve a significant number of subjects with insulin resistance, glucose intolerance or early stages of diabetes, who have not been taking supplements containing Cr for at least 4 months, and involve at least 400 to 600 microg supplemental Cr daily or more. Studies should be at least 4 months to document sustained effects of supplemental Cr on insulin resistance and related variables. Cr is a nutrient and not a therapeutic agent and therefore will only be of benefit to those whose problems are due to suboptimal intake of Cr.Keywords
This publication has 50 references indexed in Scilit:
- Chromium Chloride Inhibits Oxidative Stress and TNF-α Secretion Caused by Exposure to High Glucose in Cultured U937 MonocytesBiochemical and Biophysical Research Communications, 2001
- Control of steroid-induced diabetes with supplemental chromiumThe Journal of Trace Elements in Experimental Medicine, 1999
- Insulin Regulation of Protein Traffic in Rat Adipose CellsPublished by Elsevier BV ,1999
- Lack of toxicity of chromium chloride and chromium picolinate in rats.Journal of the American College of Nutrition, 1997
- Chromium Oligopeptide Activates Insulin Receptor Tyrosine Kinase ActivityBiochemistry, 1997
- A Biologically Active Form of Chromium May Activate a Membrane Phosphotyrosine Phosphatase (PTP)Biochemistry, 1996
- INSULIN RESISTANCE AND INSULIN DEFICIENCY IN THE PATHOGENESIS OF POSTTRANSPLANTATION DIABETES IN MANTransplantation, 1992
- Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasoneArchives of Internal Medicine, 1989
- Effect of exercise (running) on serum glucose, insulin, glucagon, and chromium excretionDiabetes, 1982
- Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic miceDiabetes, 1977